1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Donor Leukocytes: new trials by email Literature Review of Donor Leukocytes trials Research Report on Donor Leukocytes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia Gemtuzumab Ozogamicin (GO), Donor Leukocytes - Acute Myeloid Leukemia | Phase 1 / Phase 2 | Completed | Brown University | 11 | 2019-12-31 | 2026-07-23 |
Disease Progression (1) · Leukemia, Myeloid, Acute (1) · Recurrence (1)
Brown University (1)
United States (1)
John Reagan, MD (1)